Skip to main content
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.09
-0.03 (-0.49%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Xeris Biopharma Holdings Revenue

In the year 2025, Xeris Biopharma Holdings had annual revenue of $291.85M with 43.72% growth. Xeris Biopharma Holdings had revenue of $85.81M in the quarter ending December 31, 2025, with 42.78% growth.

Revenue (ttm)
$291.85M
Revenue Growth
+43.72%
P/S Ratio
3.60
Revenue / Employee
$670,908
Employees
435
Market Cap
1.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025291.85M88.78M43.72%
Dec 31, 2024203.07M39.16M23.89%
Dec 31, 2023163.91M53.67M48.68%
Dec 31, 2022110.25M60.66M122.32%
Dec 31, 202149.59M29.16M142.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Geron 183.88M
Xencor 125.58M
CytomX Therapeutics 76.20M
KalVista Pharmaceuticals 73.62M
Septerna 45.95M
uniQure 16.10M
Zenas BioPharma 10.00M
Inventiva 7.94M
Revenue Rankings

XERS News

More News